National prevalence of heart failure in type 2 diabetes patients derived from the National eHealth System and their access to treatment with SGLT2 inhibitors or GLP-1 Receptor Agonists

Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/25296

DC Field	Value	Language
dc.contributor.author	Mihajlovska Dzulijana	en_US
dc.contributor.author	Smokovski Ivica	en_US
dc.contributor.author	Kocinski Goran	en_US
dc.contributor.author	Antova, Emilija	en_US
dc.contributor.author	Petkovska, Lidija	en_US
dc.contributor.author	Bosevski, Marijan	en_US
dc.date.accessioned	2022-12-28T12:41:16Z	-
dc.date.available	2022-12-28T12:41:16Z	-
dc.date.issued	2019-10	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/25296	-
dc.description	03-06 October 2019, Ohrid, North Macedonia	en_US
dc.language.iso	en	en_US
dc.publisher	Macedonian Society of Cardiology	en_US
dc.title	National prevalence of heart failure in type 2 diabetes patients derived from the National eHealth System and their access to treatment with SGLT2 inhibitors or GLP-1 Receptor Agonists	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	Sixth Congress of the Macedonian Society of Cardiology	en_US
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers